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Several respiratory viruses, including influenza virus and severe acute respiratory syndrome coronavirus
(SARS-CoV), produce more severe disease in the elderly, yet the molecular mechanisms governing age-related
susceptibility remain poorly studied. Advanced age was significantly associated with increased SARS-related
deaths, primarily due to the onset of early- and late-stage acute respiratory distress syndrome (ARDS) and
pulmonary fibrosis. Infection of aged, but not young, mice with recombinant viruses bearing spike glycopro-
teins derived from early human or palm civet isolates resulted in death accompanied by pathological changes
associated with ARDS. In aged mice, a greater number of differentially expressed genes were observed than in
young mice, whose responses were significantly delayed. Differences between lethal and nonlethal virus phe-
notypes in aged mice could be attributed to differences in host response kinetics rather than virus kinetics.
SARS-CoV infection induced a range of interferon, cytokine, and pulmonary wound-healing genes, as well as
several genes associated with the onset of ARDS. Mice that died also showed unique transcriptional profiles
of immune response, apoptosis, cell cycle control, and stress. Cytokines associated with ARDS were signifi-
cantly upregulated in animals experiencing lung pathology and lethal disease, while the same animals expe-
rienced downregulation of the ACE2 receptor. These data suggest that the magnitude and kinetics of a
disproportionately strong host innate immune response contributed to severe respiratory stress and lethality.
Although the molecular mechanisms governing ARDS pathophysiology remain unknown in aged animals, these
studies reveal a strategy for dissecting the genetic pathways by which SARS-CoV infection induces changes in
the host response, leading to death.
Severe acute respiratory syndrome coronavirus (SARS-
CoV) is a zoonotic pathogen, likely originating from bats,
civets, and raccoon dogs, that entered the human population to
cause a global epidemic in 2002 and 2003. The epidemic was
severe, resulting in about 8,000 human infections that often
progressed to severe acute respiratory disease, pneumonia,
and diarrhea, culminating in an 10% fatality rate (10). Ad-
vanced age (60 years old) was significantly associated with
increased SARS-related deaths due to rapidly progressive re-
spiratory compromise (acute respiratory distress syndrome
[ARDS]) (13, 14). This pulmonary damage is believed to be
caused by both direct viral effects and immunopathological
factors (18). Aging is associated with increased morbidity in a
variety of viral infections (e.g., West Nile virus, influenza virus,
SARS-CoV, and noroviruses), perhaps because the elderly re-
spond poorly to new antigens compared to younger popula-
tions (41, 48). In addition, a typical feature of advanced age is
a general increase in the production and levels in plasma of
proinflammatory cytokines, resulting in an age-related increase
of inflammation (48). However, the molecular mechanisms
governing SARS-CoV pathogenesis are unclear because of the
lack of well-defined animal models that exhibit severe pulmo-
nary disease in vulnerable aged populations.
Mortality rates for ARDS, the most severe form of acute lung
injury, approach 50%, and the disease affects 1,000,000
people/year worldwide, ranking it among the most difficult chal-
lenges in critical-care medicine (31). Early ARDS is characterized
by diffuse alveolar damage (DAD), which includes a protein-
rich edema, an exudative phase with hyaline membranes, and
inflammation leading to surfactant dysfunction and severe hyp-
oxia, usually occurring within the first 10 days of acute lung
injury. This may progress to an organizing-phase DAD that
progresses to pulmonary fibrosis, and both occurred following
SARS-CoV infection. ARDS has been reported following
SARS-CoV or influenza virus infection and is sporadically
reported following herpesvirus, respiratory syncytial virus, ad-
enovirus, varicella virus, and hantavirus infections, as well (9,
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11, 30, 39, 42, 51); however, few well-defined ARDS animal
models exist. Select SARS-CoV strains and H5N1 influenza
virus are robust models for ARDS in rodents (47, 56), yet the
molecular mechanisms governing ARDS pathogenesis follow-
ing virus infection are still unclear, especially when placed into
the context of aging. Consequently, despite intensive investi-
gation, there are no specific clinical therapies for ARDS except
supportive care.
Although the pathogenic mechanisms of SARS-CoV infec-
tion remain poorly defined, studies of a limited number of
human serum (21, 24) and lung (7, 8, 20) samples have pro-
vided some insight. During SARS-CoV infection in humans, a
dysregulated cytokine and inflammatory response has been
proposed to be the cause of the pulmonary pathology charac-
terized at autopsy. High levels of type I interferons and inter-
feron-stimulated genes (ISGs), such as CXCL10, interleukin 6
(IL-6), and IL-8 genes, were seen in these patients. Some of
these genes, IL-6 and IL-8 genes, as well as others, including
tumor necrosis factor alpha (TNF-) and IL-1 genes, have
also been associated with ARDS (4, 37), though gene and
protein expression profiles from these patient samples were
likely impacted by clinical treatments (steroids and mechanical
ventilation) and concurrent preexisting disease, such as chronic
heart failure, diabetes, and asthma. In addition, these patient
samples are more likely to represent late-stage disease. Animal
models of SARS-CoV that recapitulate the ARDS outcome in
humans, especially that seen in the elderly, may reveal the
initial host-virus responses that contribute to severe end stage
lung disease.
We recently isolated an isogenic panel of recombinant in-
fectious-clone (ic) SARS-CoV strains bearing different spike
(S) glycoproteins derived from a zoonotic SARS-CoV strain,
icHC/SZ/61/03, and from strains identified during the late and
early phases of the human epidemic, icUrbani and icGZ02,
respectively (47, 57). In aged mice, icUrbani infection caused
mild disease with transient weight loss (44), while icGZ02 and
icHC/SZ/61/03 resulted in severe lung infection progressing to
acute-onset DAD, ARDS, and death (47). In contrast, young
mice replicated virus in the absence of clinical disease symp-
toms and lung pathology, regardless of the origins of the S
glycoprotein. These data implicate changes in the S glycopro-
tein gene as major components of SARS-CoV pathogenesis.
Here, we compare host responses over time in nonlethal and
lethal mouse models of SARS-CoV using gene expression data
to more fully understand the impacts of aging and viral-spike
variation on the host response that regulates severe disease
phenotypes and the onset of ARDS.
MATERIALS AND METHODS
Viruses and cells. The generation and characterization of each of the recom-
binant ics (icUrbani, icGZ02, and icHC/SZ/61/03) have been described previ-
ously (47, 57). Briefly, all recombinant icSARS-CoV strains were propagated on
Vero E6 cells in Eagle’s minimal essential medium (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal calf serum (HyClone, Logan, UT), kanamycin
(0.25 g/ml), and gentamicin (0.05 g/ml) at 37°C in a humidified CO2 incubator.
All work was performed in a biological safety cabinet in a biosafety level 3
laboratory containing redundant exhaust fans. Personnel were equipped with
powered air-purifying respirators with high-efficiency particulate air and organic
vapor filters (3 M, St. Paul, MN), wore Tyvek suits (DuPont, Research Triangle
Park, NC), and were double gloved.
Mouse infection. Female BALB/cAnNHsd mice (young [8 weeks old] or aged
[12 months old]; Harlan, Indianapolis, IN) were anesthetized with a ketamine
(1.3 mg/mouse)-xylazine (0.38 mg/mouse) mixture administered intraperitone-
ally in a 50-l volume. Groups of 20 mice were intranasally inoculated with
phosphate-buffered saline (PBS) (mock infection) or 105 PFU of icUrbani,
icGZ02, or icHC/SZ/61/03 in a 50-l volume. The weights of the mice were
monitored daily. At 3, 12, 24, 48, and 72 h postinfection (p.i.), four mice from
each group were euthanized, and lung and serum samples were collected. Be-
cause the mice died by 96 h p.i. (47), mice were sacrificed through 72 h p.i. to
ensure good-quality RNA for gene expression studies. For each mouse, one half
of a lung was frozen at 70°C for RNA isolation. One half of a lung from each
mouse was taken for RNA extraction, one quarter of a lung was assayed for viral
titers by plaque assay, and one quarter was saved for immunohistochemical
detection of the SARS-CoV nucleocapsid (N) protein. All mice were housed
under sterile conditions in individually ventilated Sealsafe cages using the Slim-
Line system (Tecniplast, Exton, PA). Experimental protocols were reviewed and
approved by the Institutional Animal Care and Use Committee at the University
of North Carolina, Chapel Hill.
Virus titers in tissue samples. Lung samples were weighed and homogenized
in five equivalent volumes of PBS to generate a 20% solution. The solution was
centrifuged at 13,000 rpm under aerosol containment in a table top centrifuge for
5 min, the clarified supernatant was serially diluted in PBS, and 200-l volumes
of the dilutions were placed onto monolayers of Vero E6 cells in six-well plates.
Following 1 hour of incubation at 37°C, the cells were overlaid with 0.8%
agarose-containing medium. Two days later, the plates were stained with neutral
red and the plaques were counted.
Immunohistochemistry. All tissues were fixed in 4% paraformaldehyde in PBS
(pH 7.4) for at least 7 days prior to being submitted to the Histopathology Core
Facility (University of North Carolina, Chapel Hill) for paraffin embedding. For
detection of SARS-CoV antigen, serial sections were deparaffinized and rehy-
drated, and antigen was retrieved by incubating the sections at 100°C for 15 min
with citric acid buffer, pH 6.0. Slides were cooled for 20 min on ice in the same
solution. Endogenous peroxidase was blocked with 3% hydrogen peroxide. The
slides were briefly washed with PBS/0.05% Tween 20 and incubated with serum
from ferrets infected with SARS-CoV (1/400 in PBS/0.1% bovine serum albu-
min) or normal ferret serum (1/400) for 1 h at room temperature. After being
washed, the sections were incubated with horseradish peroxidase-labeled goat-
anti-ferret immunoglobulin G (KPL, Inc., MD) in PBS/0.1% bovine serum al-
bumin for 1 h at room temperature. Peroxidase activity was revealed by incu-
bating the slides in 3-amino-9-ethylcarbazole (Sigma, St. Louis, MO) for 10 min,
resulting in a bright-red precipitate, followed by counterstaining with hematox-
ylin. Tissue sections from noninfected mice were used as negative controls. Lung
sections from an experimentally SARS-CoV-inoculated ferret euthanized at 24 h
p.i. were used as positive controls. Using polyclonal ferret sera directed against
the SARS-CoV N protein, viral N protein was detectable as a measure of
replication in the lungs of mice no earlier than 24 h p.i.
RNA isolation and genomic precharacterization. One half of a lung from each
mouse was transferred to solution D (4 M guanidine thiocyanate with 25 mM
sodium citrate, 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol) and homogenized,
and RNA was extracted and purified as described previously (25). Using an
Agilent 2100 bioanalyzer (Agilent Technologies Inc., Palo Alto, CA), total RNA
samples from individual mice extracted at the time points 3, 12, 24, 48, and 72 h
p.i. were characterized and judged to be pure and intact. The RNA samples were
then tested by relative quantitative real-time reverse transcription (RT)-PCR
(described below) for the presence of the SARS-CoV N gene and cellular
transcripts Cxcl9, Cxcl10, Irf7, and B2m to determine if individual samples could
be pooled to generate one representative experimental sample to be used for
gene expression analysis. Most samples had similar viral and cellular transcripts;
therefore, equal-mass quantities of total RNA extracted from individual samples
were pooled to create an experimental gene expression sample. Mice at 12 h p.i.
showed considerable variation in viral transcripts, with only one out of four
young mice and three out of four aged mice with detectable viral transcripts;
therefore, a different pooling strategy was used. A representative young-mouse
sample of host response to virus at 12 h p.i. was created from total RNA from the
one individual sample with viral transcripts, and a representative aged-mouse
sample of host response to virus at 12 h p.i. was created from equal-mass
quantities of total RNA from the three individual samples for aged mice with
viral transcripts. In contrast, viral and cellular transcripts were equivalent at all
other time points, allowing the samples to be pooled.
Oligonucleotide microarray analysis. cRNA probes were generated from each
pooled RNA sample using the Agilent Low RNA Input Fluorescent Linear
Amplification kit (Agilent Technologies Inc., Palo Alto, CA). Each pooled ex-
perimental RNA sample was then cohybridized with its corresponding reference
sample, i.e., young experimental mice versus young mock-infected mice and aged
experimental mice versus aged mock-infected mice. In addition, one microarray
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experiment was performed comparing the pooled young mock-infected reference
to the pooled aged mock-infected reference to directly gain insight into the
effects of aging. All microarray hybridizations were performed with mouse oli-
gonucleotide arrays (G4121B; Agilent Technologies Inc.). Slides were scanned
with an Agilent DNA microarray scanner, and image analysis was performed
using Agilent Feature Extractor Software (Agilent Technologies Inc.). Each
microarray experiment was done with four technical replicates, two with reverse
dye hybridization (28). All data were entered into a custom-designed database
(Expression Array Manager) and analyzed with Resolver 6.0 (Rosetta Biosoft-
ware, Seattle, WA) and Spotfire DecisionSite for Functional Genomics 8.1
(Tibco Spotfire, Somerville, MA). Ingenuity Pathway Analysis 6.0 (Ingenuity
Systems, Redwood City, CA) was used to functionally annotate genes according
to biological processes and canonical pathways. Genes were included in all
analyses based on the criteria that the absolute expression level change was
twofold or greater with a P value of 0.01, unless otherwise stated.
A gene set enrichment analysis (GSEA) (53) was used to identify sets of genes
annotated by the same function in the gene ontology (GO) (1) that were differ-
entially expressed during infection. In preparation for this analysis, the Rosetta
Resolver System was used to determine the P value of the differential expression
of each gene compared to the mock sample. In short, given a list of genes for a
single virus/time point combination ranked in decreasing order by the log(P
value), GSEA allows the identification of gene sets that are concentrated at the
top of the list (signifying significant differential expression). For every function in
GO, a GSEA was applied to each virus/time point combination. A dynamic
program method was used to determine the exact P value for each GO function
(27). Only the significances of GO functions with a depth of at least 4 in the GO
hierarchy were tested to avoid nonspecific terms. For each function, plots of the
log(P value) were generated for each virus to track the significance of the
function across all time points.
Relative quantitative real-time RT-PCR. Relative quantitative real-time RT-
PCR was performed to precharacterize individual mouse samples before pooling
them, to validate a number of cellular-gene expression changes detected by
microarray in pooled samples, and to further characterize a subset of transcripts
in an expanded time course of viral infection. Total-RNA samples were treated
with DNase using a DNA-free DNase kit (Ambion, Inc. Austin, TX). cDNA was
generated using RT reagents and random hexamers (Applied Biosystems, Foster
City, CA). Relative quantitative real-time RT-PCR was run on the ABI 7500
PCR system, using TaqMan chemistry (Applied Biosystems, Foster City, CA).
Primers and probes specific for the nucleoprotein gene of SARS-CoV have been
described previously (12), and primers and probes specific for mouse cellular
genes were purchased from Applied Biosystems as “gene expression assays.”
Targets were run in quadruplicate following protocols supplied by Applied Bio-
systems (Foster City, CA).
Microarray data accession numbers. All data described in this report, includ-
ing sample information, intensity measurements, gene lists, error analysis, mi-
croarray content, and microarray hybridization conditions, will be available after
publication in the public domain through Expression Array Manager at http:
//expression.viromics.washington.edu in accordance with proposed standards (6).
RESULTS
S glycoproteins affect clinical outcomes and viral replication
in young and aged mice infected with icSARS-CoV. As previ-
ously shown, infection of young BALB/c mice with icUrbani,
icGZ02, or icHC/SZ/61/03 did not result in weight loss or other
clinical signs of disease, regardless of the origin of the S gly-
coprotein (Fig. 1A) (47). Infection of aged BALB/c mice with
icUrbani resulted in only minor weight loss of 5% with no
other signs of clinical disease. In contrast, aged mice infected
with either icGZ02 or icHC/SZ/61/03 exhibited significant
weight loss of10% by 72 h p.i. (Fig. 1B) and exhibited clinical
symptoms, including hunching, ruffled fur, and labored breath-
ing. As seen previously in the lungs, DAD, hyaline membrane
formation, and alveolitis were noted with icGZ02 and icHC/
SZ/61/03, but not after icUrbani infection (reference 47 and
data not shown).
In young mice, icUrbani replicated to peak titers of 8 107
FIG. 1. Differences in clinical outcomes did not correlate with differences in viral replication efficiencies. Weight loss (A and B) and lung titer
(C and D) results are shown for 8-week-old (young) (A and C) and 12-month-old (aged) (B and D) female BALB/c mice infected with icUrbani,
icGZ02, and icHC/SZ/61/03. (A and B) Body weights of infected mice were measured on a daily basis (n 	 5 per group). Weight changes are
expressed as the mean percent changes for infected animals relative to the initial weights at day zero. Lung tissues were harvested from infected
mice at 3, 12, 24, 48, and 72 h p.i. and assayed for infectious virus as described in Materials and Methods. Tissue samples from five mice were
analyzed at each time point. The error bars represent standard deviations.
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PFU/g in lungs, while icGZ02 replicated to peak titers of 2 
107 PFU/g and icHC/SZ/61/03 replicated to peak titers of 6 
105 PFU/g of lung tissue under identical conditions (Fig. 1C).
Viral titers peaked at 24 h p.i. for icGZ02 and icHC/SZ/61/03,
after which icGZ02 titers dropped while icHC/SZ/61/03 titers
remained consistent. Conversely, icUrbani replicated as effi-
ciently as icGZ02 during the first 24 h p.i. but continued to
replicate and reached peak titers at 48 h p.i. While clear dif-
ferences in viral replication were observed, this did not extend
to clinical differences, which were absent in young mice.
In aged mice, peak titers were 1 log unit higher for icGZ02
and 2 log units higher for icHC/SZ/61/03 than titers in young
mice (Fig. 1D). Similar to that in young mice, viral replication
peaked at 24 h p.i. for icGZ02 and icHC/Z/61/03 and at 48 h
p.i. for icUrbani. Unique to aged mice, viral titers dropped 1 to
2 log units after reaching peak titers for all viruses. While clear
differences in clinical outcomes were observed between non-
lethal icUrbani and lethal icGZ02 and icHC/SZ/61/03 isolates,
these differences could not be attributed to virus growth effi-
ciencies in the lungs of infected aged mice, suggesting that
intrinsic properties of the S glycoprotein contributed to differ-
ences in pathogenesis.
S glycoproteins affect the tropism of SARS-CoV replication
in lungs of infected mice. As the recombinant SARS-CoV
panel was isogenic except for defined sequence variations
unique to each S glycoprotein gene (47), we next determined if
these spike changes altered virus tropism in the lungs of young
and aged animals at early and late time points p.i. Using poly-
clonal ferret sera directed against the SARS-CoV N protein,
unique patterns of viral N protein distribution were clearly
detectable in the lungs of all infected young and aged mice by
24 h p.i. (Fig. 2). With icUrbani, a small number of scattered
alveolar epithelial cells, with morphology consistent with type
II pneumocytes, stained positive for SARS-CoV N protein at
24 h p.i. in both young and aged animals. Increasing numbers
of alveolar epithelial cells that expressed viral N protein were
observed at 48 and 72 h p.i. (Fig. 2 and data not shown). In
contrast, the lungs of mice infected with icGZ02 and icHC/SZ/
61/03 SARS-CoV displayed distinctly different infection pat-
terns and cell tropism. Viral N protein expression was localized
in a small number of bronchial and bronchiolar epithelial cells
in the airways and scattered alveolar cells with type II pneu-
mocyte appearance as early as 12 h p.i. (data not shown). By
24 h p.i., viral N protein expression was localized in a moderate
number of bronchial and bronchiolar epithelial cells and a few
scattered alveolar epithelial cells, again with morphology con-
sistent with type II pneumocytes. By 48 h p.i. the majority of
viral N protein was detected in these alveolar epithelial cells,
with occasional detection in bronchial cells, bronchiolar cells,
and cellular debris that was evident in the preterminal bron-
chioles. By 72 h p.i., viral N protein expression could be de-
tected only in alveolar epithelial cells with type II pneumocyte
appearance, with no bronchial or bronchiolar involvement and
little cellular debris. These data indicate that the changes in the
SARS-CoV S glycoprotein altered the tropism and pathogen-
esis in aged mice.
Decreased ACE2 expression correlates with lethal outcome
of SARS-CoV infection. Since the SARS-CoV receptor ACE2
has been shown to be downregulated by the SARS-CoV S
glycoprotein (32), causing deregulation of the rennin-angioten-
sin system and exaggeration of acute lung failure, we hypoth-
esized that the expression pattern of ACE2 would be differen-
tially altered during lethal infections compared with nonlethal
infections. Several attempts to detect murine ACE2 in the
FIG. 2. Tropism of lethal SARS-CoV is primarily for bronchial and bronchiolar cells at early stages of infection, while that of nonlethal
SARS-CoV is primarily for alveolar epithelial cells. With SARS-CoV icUrbani (top row), alveolar epithelial cells of aged mice showed SARS-CoV
N immunohistochemical staining, with greater numbers of alveolar epithelial cells being stained (arrows with closed arrowheads) as the infection
progressed. With icGZ02 and icHC/SZ/61/03 (middle and bottom rows), SARS-CoV N staining was observed in many bronchial and bronchiolar
cells (arrows with open arrowheads) and few alveolar epithelial cells at 24 h p.i. in aged mice. At 48 and 72 h p.i., the numbers of bronchial and
bronchiolar cells positive for N decreased while the number of alveolar epithelial cells positive for N increased. In addition, positive staining was
also observed in intraluminal debris (asterisks). Immunoperoxidase with hematoxylin counterstain was used. Magnification, 20.
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lungs of infected mice by immunohistochemistry were unsuc-
cessful. As an alternative, we used real-time RT-PCR to ex-
amine the regulation of ACE2 in infected lungs (Fig. 3). In
aged mice, at 48 h p.i., ACE2 was downregulated three- and
fivefold during lethal icGZ02 and icHC/SZ/61/03 infections,
respectively (Fig. 3A), supporting the idea that downregulation
of ACE2 leads to acute lung failure. In contrast, the nonlethal
icUrbani-infected mice upregulated ACE2 twofold over mock-
infected mice at 48 h (Fig. 3A), correlating with mouse survival
and indicating that the icUrbani S glycoprotein is not as patho-
genic as the icGZ02 or icHC/Sz/61/03 S glycoprotein. In young
mice, ACE2 expression was significantly downregulated only
after infection with icHC/SZ/61/03 at 72 h p.i. (Fig. 3B). These
data show that early downregulation of ACE2 is associated
with lethal disease and therefore that ACE2 may potentially
play a protective role in SARS-CoV-induced lung injury.
Global gene expression in lungs of aged SARS-CoV-infected
mice shows an early host response to virus compared with that
in young SARS-CoV-infected mice. Pulmonary gene expression
comparison in young and aged mice infected with nonlethal
and lethal SARS-CoV strains provides an opportunity to
identify unique expression signatures associated with lethal
infection that could reveal the molecular mechanisms of
SARS-CoV pathogenesis. In young mice, a late response to
SARS-CoV infection was observed at 72 h p.i., with similar
numbers of genes differentially expressed between mice in-
fected with the different SARS-CoV isolates at each time point
(Fig. 4A). In contrast, the host response in aged mice was
characterized by an early (24-h p.i.) onset of differential gene
expression that continued up to 72 h p.i. In aged mice, a
greater number of genes were differentially expressed during
infection with lethal SARS-CoV isolates than with the nonle-
FIG. 3. Expression of ACE2 is downregulated in lethal infection of
aged mice. Quantitative RT-PCR using TaqMan chemistry was per-
formed on individual lung samples from aged (A) and young (B) an-
imals at 12, 24, 48, and 72 h p.i. The changes over aged and young
mock controls, respectively, are plotted. The error bars represent stan-
dard deviations. *, P 
 0.01 (analysis of variance; Bonferroni posttest
compared to icUrbani).
FIG. 4. Global gene expression profiles show a prominent kinetic
difference in gene expression, with aged mice initiating an earlier gene
transcription response to viral infection than young mice. (A) Global
gene expression data are the results of a comparison of gene expres-
sion in the lungs of experimental mice versus gene expression in the
lungs of mock-infected mice, and genes were included if they met the
criteria of an absolute change of 2-fold (P  0.01) in at least two
experiments. Each bar represents one microarray experiment (n 	 4).
Y, young; A, aged; U, icUrbani; G, icGZ02; H, icHC/SZ/61/03 (12, 24,
and 72 h p.i.). (B) Genes were included in the heat map if they showed
an absolute change of 2-fold (P  0.01) in at least one experiment.
These data were plotted as a heat map in which each matrix entry
represents a gene expression value. Red corresponds to gene expres-
sion higher than that of the reference; green corresponds to lower gene
expression. Data are presented for young and aged mice infected with
either icUrbani (U), icGZ02 (G), or icHC/SZ/61/03 (H) at the indi-
cated time points.
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thal isolate, with the lethal icHC/SZ/61/03 strain inducing
greater numbers (200 more) of genes at 24 and 72 h p.i. than
the lethal icGZ02 strain. The number of differentially regu-
lated genes correlated with pathogenicity, as in previous results
(47), showed that icUrbani does not cause lethal disease,
icGZ02 causes a pathogenic disease that kills 75% of infected
mice by day 4, and icHC/SZ/61/03 causes lethal disease in
100% of infected mice starting as early as day 3.
Plotting global gene expression profiles as heat maps showed
few commonly regulated genes between the three different
viruses at early time points in both young and aged mice, while
similarities became apparent at 72 h p.i. (Fig. 4B). At this later
stage of infection in aged and young mice, all three viruses
induced a large number of unique genes but also showed the
greatest number of common genes (Fig. 5). Notably, at 72 h
p.i., aged mice displayed approximately 10-fold-greater num-
bers of differentially expressed genes specific to both lethal
virus infections than young mice. This trend was also noted at
24 h p.i., and the gene responses specific to lethal isolates in the
aged mice outnumbered the gene responses common to all
three isolates in aged mice. Interestingly the number of differ-
entially expressed genes unique to lethal infection with icHC/
SZ/61/03 in aged mice was threefold higher than the number of
genes unique to lethal infection with icGZ02. These data sug-
gest that the lethal strains may produce severe disease pheno-
types by different molecular mechanisms, and survival out-
comes may be decided as early as 24 h p.i.
In order to better understand the biological functions asso-
ciated with lung pathology and lethal disease at early stages of
infection, we analyzed the microarray results using GO func-
tional annotations. A GSEA (described in Materials and
Methods) of the GO functionally annotated data was used to
determine whether specific functional classes of genes were
differentially regulated in response to infection. This analysis
revealed significant differential expression of genes associated
with immune response and apoptotic functional classes to
SARS-CoV infection at 24 h p.i. (Fig. 6A). Lymphocyte-medi-
ated immunity, apoptosis, and inflammatory response func-
tional classes were significantly correlated, with the severity of
disease with icGZ02- and icHC/SZ/61/03-infected aged ani-
mals showing the greatest statistical association of these
classes. Interestingly, by 72 h p.i., these functional classes were
no longer correlated with lethal disease but instead showed a
common response to SARS-CoV infection. These results could
also be observed when the data were plotted as a heat map: the
host response to virus infection established at 24 h p.i. seem to
determine the outcome for aged mice infected with lethal
SARS-CoV strains, which was different from aged mice in-
fected with a nonlethal strain and all infected young mice (Fig.
6B). Both of these graphical formats showed that the response
at 24 h is an important determinant of the disease outcome due
to an aberrant host response.
Host response at 24 h after lethal infection. Since the host
response at 24 h p.i. is clearly a determinant of the disease
outcome, data from this time point were further examined to
identify regulatory pathways that might provide a possible ex-
planation for lung pathology and mortality. Ingenuity pathway
analysis was used to identify the top canonical pathways in-
duced in the 24-h p.i. data sets from the lethal models. Inter-
feron signaling and acute-phase response were found to be the
top canonical pathways induced during icGZ02 and icHC/SZ/
61/03 infection. The kinetics of a subset of genes from the
interferon signaling and acute-phase response pathways was
confirmed by real-time RT-PCR (Fig. 7). As with the func-
tional annotation, expression of genes in these canonical path-
ways was correlated with pathogenicity in the aged mice at 24 h
p.i., but not in young mice (Fig. 8). The data again revealed
that similarities became apparent among the different infection
systems at 72 h p.i. Of particular note, the acute-phase re-
sponse pathway included a number of cytokines previously
identified as important in the development of ARDS, including
IL-1, IL-6, and TNF (7, 8), as well as several members of the
complement cascade.
In addition, upon SARS-CoV infection in either young or
aged mice, both beta interferon (IFN-) and IFN-, but not
IFN-, were significantly upregulated, as previously observed
in other animal models of SARS-CoV infection (3, 12). Many
of the ISGs were also upregulated, including Ifit3 and Irf9
genes. The temporal regulation of many of these individual
cytokine genes mirrored the kinetics of the global gene expres-
sion of host responses; strong upregulation of these genes was
observed by 24 h p.i. in aged mice infected with icGZ02 and
icHC/SZ/61/03, but these same responses during nonlethal
icUrbani infection were delayed until 72 h p.i. These data
establish the aged-mouse model as an animal model for virus-
induced ARDS and suggest that interferon signaling and the
acute-phase response, including the complement system, play
pivotal roles in the outcome of viral infection and SARS-CoV
pathogenesis.
Differences in the host responses between two lethal SARS-
CoV strains. In order to assess the host response differences
between the two lethal SARS-CoV strains, which could be
FIG. 5. Viruses show more similar profiles of differentially ex-
pressed genes as time progresses. The Venn diagram shows the overlap
of genes with 2-fold change (P  0.01) between icUrbani, icGZ02,
and icHC/SZ/61/03 in young and aged mice over time. Data are pre-
sented for young (Y) and aged (A) mice infected with either icUrbani
(U), icGZ02 (GZ), or icHC/SZ/61/03 (HC) at the indicated time points
p.i. The numbers in the centers were shared by all three viruses.
VOL. 83, 2009 PATHOGENESIS OF LETHAL SARS-CoV INFECTION 7067
FIG. 6. Functional enrichment of disease-related pathways reveals the importance of kinetics in the host response. (A) GSEA (described in
Materials and Methods) was performed on the change data for all experiments using GO classes. GO categories 6954 (inflammatory response),
6915 (apoptosis), and 2449 (lymphocyte-mediated immunity) were chosen for further investigation based on their high P values. The P values for
these categories were plotted as a function of time p.i. for infections of young (Y) and aged (A) animals infected with icUrbani (U), icGZ02 (G),
or icHC/SZ/61/03 (H). (B) Expression data are shown for young and aged mice infected with icUrbani (U), icGZ02 (G), or icHC/SZ/61/03 (H) for
24 and 72 h p.i. Genes were selected by GSEA within the GO categories inflammatory response (pink bar), apoptosis (blue bar), and
lymphocyte-mediated immunity (green bar), with the additional condition that at least one experiment met the cutoff change of 1.5-fold (P 

0.01). The experiments are clustered using the unweighted-pair group method using average linkages, with similarity determined by Euclidean
distance and ordering by average value. The column dendrogram, showing the relative similarity of the experiments, is at the top. The data for aged
icUrbani-infected mice at 24 h p.i. clusters more distantly with the data for young mice at 24 h p.i. (bold gray line) than the data for aged mice
at 24 h p.i. Bold black line, icGZ02 and icHC/SZ/61/03 data.
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potential determinants of disease outcome, a gene interaction
network was created, associated with early host response (24 h
p.i.). The network was created by including genes that showed
differential regulation that was unique in response to the lethal
icGZ02 and icHC/SZ/61/03 infections (Fig. 9). The network
analysis is useful to assess genes acting in concert within and
between different functional processes and represents a com-
bined interaction network generated with the top two networks
identified by ingenuity pathway analysis (details are provided
in the legend to Fig. 9). The interaction network shows the four
broad functional classes of immune response, apoptosis, cell
cycle control, and translational control/endoplasmic reticulum
(ER) stress, acting in concert and shows that icGZ02 infection
regulates a subset of the genes whereas icHC/SZ/61/03 infec-
tion regulates all of the genes in the network. This enhanced
host response to icHC/SZ/61/03 infection at 24 h p.i. provides
a possible explanation for prior mortality data (47) that showed
that icGZ02 killed 75% of the animals by day 4 whereas HC/
SZ/61/03 killed 100% of the animals starting as early as day 3.
The enhanced 24-h p.i. host response to icHC/SZ/61/03 infec-
tion is of particular interest, because at this stage of infection,
the lungs of aged mice show viral loads of icHC/SZ/61/03 (6 
105 PFU/g) lower than the viral loads of icGZ02 (2  107
PFU/g) (Fig. 1), and therefore, this earlier and enhanced re-
sponse may potentially represent a host immunopathologic
contribution to SARS pathogenesis.
DISCUSSION
Despite intensive studies, there are currently no specific
therapies for ARDS, especially following virus infection, and
model systems are desperately needed. While several viruses
are known to cause ARDS, including SARS-CoV and influ-
enza virus (9, 11, 30, 39, 42, 51), the molecular mechanisms of
virus-induced ARDS are not well characterized due to the
limited number of available animal models. The recent recon-
struction of two lethal SARS-CoV infection models in mice
that recapitulate the age-related pathogenic phenotype noted
in humans (47) provided us with the novel opportunity to
characterize host response kinetics and to more fully develop
the model for characterizing the molecular mechanisms of
virus-induced ARDS. The main goals of this paper were to use
systems biology approaches with SARS-CoV-infected aged
and young mice to (i) characterize disease progression as dis-
FIG. 7. Confirmation of select gene expression results using RT-PCR. Quantitative RT-PCR for Cxcl10 (A), Ccl2 (B), IFN- (C), IL-1 (D),
IL-6 (E), and TNF (F) was performed on all separate lung samples from aged animals at 12, 24, 48, and 72 h p.i., with the exception of that for
Cxcl10, which was not performed at 48 h. The data are shown as changes over mock-infected controls. The error bars represent standard deviations.
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tinguishable gene expression profiles and (ii) validate the aged-
mouse model of SARS as representative of ARDS.
In this study, both lethal and nonlethal isolates grew to high
titers in the lungs of infected mice but showed different tro-
pisms and abundances of virus-infected cells in the lungs,
which were correlated with increased pathological findings.
The molecular mechanisms governing tropism differences im-
parted by the S glycoprotein are unknown. It has been shown
that mutations in the S glycoprotein are responsible for differ-
ences in receptor affinity during adaptation (34). All of the S
glycoprotein mutants used in this study required ACE2 as their
receptors. However, expression of ACE2 alone was not suffi-
cient for replication of the zoonotic strains in human airway
epithelium cells (47). These data suggest that the differences in
tropism could reflect differential affinities for murine ACE2
receptors or for DC/L-Sign coreceptors (34). Future studies to
characterize localizations and levels of ACE2 in murine lung
cell types are imperative, as type I and type II human pneu-
mocytes, as well as human bronchial epithelial cells, express
ACE2 (19, 50). Differences in the tropism of target cells and
disease severity have also been observed between infections
with human and avian influenza virus strains (55). We specu-
late that like that of influenza virus, SARS-CoV tropism is a
necessary factor but is not sufficient to explain differences in
the severity of disease progression (55). Our observation that
downregulation of ACE2 correlates with lethality agrees with
earlier studies showing that SARS-CoV S glycoprotein wors-
ens acute lung failure in mice (32). ACE2 has been suggested
to regulate the host response by exaggerating acute lung failure
through deregulation of the rennin-angiotensin system, pulmo-
nary vascular tone/permeability, and epithelial cell survival (23,
31, 32, 35); therefore, future experiments evaluating SARS-
CoV-induced lung pathology during modulation of RAS gene
family members would be informative.
Considering that all three viral isolates replicated to similar
titers in the lungs of aged animals, specific changes in the S
glycoprotein seem to have triggered an aberrant host response.
Similar effects of changes in virulence have been described for
variants of the influenza virus hemagglutinin and neuramini-
dase, which also show differences in pathogenicity, linked with
FIG. 8. Canonical pathway regulation correlates with pathogenesis and lethality. At 24 h p.i., the top canonical pathways associated with lethal
infections of aged mice (the significance criteria were 1.5-fold change with a P value of 
0.01) are interferon signaling (P 	 2.75  1014 for
HC/SZ/61/03 and P	 4.75  1014 for GZ02) and acute-phase response (P	 1.62  109 for HC/SZ/61/03 and P	 5.2  109 for GZ02). These
pathways are not as significantly upregulated by pathogenic but nonlethal infection (aged animals infected with Urbani, interferon signaling, P 	
5.26  105, and acute-phase response, P 	 1.88  102). Expression data for genes in these pathways are shown as a heat map for young and
aged mice infected with icUrbani (U), icGZ02 (G), or icHC/SZ/61/03 (H) for 24 and 72 h p.i. The “NM” numbers on the right are GenBank
accession numbers.
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upregulation of genes associated with apoptosis and tissue
injury (25). SARS-CoV infection in aged mice promotes rapid
and fatal disease by influencing, not the kinetics of viral rep-
lication, but rather the host response kinetics. Aged mice
showed an early host response dominated by the induction of
inflammatory cytokines and an acute-phase response at 24 h
p.i. The differences in host gene expression, as well as cell
tropism and peak viral replication, at early time points in aged
mice infected with lethal SARS-CoV isolates indicate that the
first 24 h p.i. are critical to the clinical outcome. This is in
agreement with the observation that p.i. treatment of SARS-
CoV-infected mice with a neutralizing monoclonal antibody
did not protect them from death in the absence of virus rep-
lication at later time points (46). Disease outcome was most
affected by lymphocyte-mediated immunity, inflammatory re-
sponse, and apoptosis, as well as pathways of interferon sig-
naling and acute-phase response. In contrast, at 72 h p.i.,
common patterns of regulation occurred regardless of the dis-
ease outcome. Interestingly, an enhanced host response to
icHC/SZ/61/03 infection compared with icGZ02 infection was
FIG. 9. A network of genes suggests lethality in aged mice. The network was created by importing genes meeting the selection criteria
(1.5-fold change; P  0.01 at 24 h p.i. in either the icHC/SZ/61/03-infected aged-mouse or icGZ02-infected aged-mouse experiments, but not
the icUrbani-infected aged-mouse experiment) in ingenuity pathways analysis (IPA). The top two networks built by IPA were chosen and merged,
keeping only “direct” IPA-curated interactions. Genes were separated into functional classes based on ingenuity functional annotations. The circles
represent individual genes or protein complexes in the network and are colored according to the expression pattern observed in aged animals
infected with icGZ02 spike variant virus at 24 h p.i. (A) or icHC/SZ/61/03 spike variant virus at 24 h p.i (B). The arrows represent direct biological
interactions. The circles colored in shades of red represent genes upregulated in lethal infection versus mock infection. Pink indicates 1.5- to
2.0-fold change, red indicates 2.0- to 5.0-fold change, and dark red represents a 5-fold change. Likewise, light-green circles represent down-
regulation and indicate a 1.5- to 2.0-fold change. Gene names colored blue are differentially regulated by icHC/SZ/61/03 infection, but not icGZ02
infection, and are therefore associated with increased lethality.
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observed that provides a possible explanation for the enhanced
lethality of icHC/SZ/61/03 previously observed (47). This en-
hanced host response was indicated by a greater number of
differentially expressed genes, larger absolute change of these
genes, and a more extensive network of genes acting in concert
during icHC/SZ/61/03 infection. Because the more lethal virus
showed a lower viral load yet a greater host response, these
results suggest a potential immunopathologic contribution to
disease by the early response of the host. This phenomenon is
similar to responses seen in several animal models of viral
pathogenesis (3, 12), including hemagglutinin/neuraminidase
variants of influenza virus (25, 26), and could be described as
a more inclusive example of the phenomenon previously de-
scribed as a “cytokine storm” (21).
This “cytokine storm” observed in SARS-CoV-infected mice
paralleled that in SARS patients, including Cxcl-10, IL-1,
IL-6, TNF, and IFN- (21). The kinetics of these cytokine and
interferon responses in mice is similar to that in human cases
of ARDS, including SARS-CoV-induced cases. Cytokines are
significantly increased at the onset of ARDS in nonsurvivors
compared to survivors, with persistent elevation over time pre-
dicting a poor outcome (8, 37, 54). In addition, SARS-CoV-
infected patients with poor outcome show deviated ISG and
immunoglobulin gene expression early in infection and persis-
tent chemokine levels (8). Our data clearly showed that key
inflammatory mediators, including IL-1, IL-6, and TNF, were
upregulated, with all responses being much more robust early
during infection with the lethal isolates, in agreement with
previous clinical studies (8, 54). In support of this study, IL-1
receptor-deficient mice survived infection with a lethal mouse-
adapted SARS-CoV strain (49), suggesting a role for IL-1 in
SARS-CoV inflammation-induced pathogenesis. These in-
flammatory mediators have been shown to play an important
role in the exudative phase of ARDS pathophysiology (43).
Interferon has also been suggested to play a role in ARDS
pathophysiology, but what that role is has been less clear.
Here, mouse interferon responses were increased early in le-
thal infection with a delayed response after nonlethal SARS-
CoV infection. Previously, in vitro data have suggested that
SARS-CoV infection blocks the interferon response through
several mechanisms (15, 16, 29), while in vivo data from hu-
mans, nonhuman primates, and mice have suggested that early
SARS-CoV infection results in robust type I and II interferon
responses, as well as increased ISG expression (3, 8, 12). Stud-
ies of nonhuman primates at the cellular level bridge these
results to show that cells infected with SARS-CoV cannot
produce interferon but are capable of activating uninfected
neighboring cells to produce an interferon response (12).
In addition to uncovering interferon signaling and compo-
nents of an aberrant host response that contribute to lethality,
mouse data also revealed differential gene expression in the
complement cascade, as well as a novel regulatory network that
could distinguish two lethal phenotypes. Complement activa-
tion has been shown to play a role in ARDS (22, 58), as well as
in the pathogenesis of other viruses, including arboviruses,
dengue virus, and respiratory syncytial virus (2, 38, 40). Studies
regarding the involvement of the complement system in SARS-
CoV pathogenesis are currently ongoing in our laboratory.
Interestingly, gene expression analysis revealed a regulatory
network made up of cell cycle, apoptosis, ER stress, and im-
mune response genes working in concert to affect the progres-
sion of pathogenesis in aged animals. Both lethal phenotypes
are associated with a strong regulation of immune pathways,
including NF-B signaling and upregulation of IFN- and
translational-control/ER stress pathways, including DNAJC3
(p58IPK). p58IPK was previously shown to be a virulence factor
during influenza infection (17) and could play a similar role
during virus-induced ARDS. During viral infection, transla-
tional-control and cell cycle genes are expected to inhibit viral
replication, and immune and apoptotic pathways kill infected
cells. However, if this response occurs early in infected cells
with strong upregulation of these genes, uninfected tissues can
also suffer the effects of this uncontrolled immune response,
similar to that seen in macaque studies (12). Moreover, up-
regulation of apoptotic genes primes the cells for death rather
than survival in a manner consistent with the two lethal phe-
notypes. In animals infected with icGZ02, a small number of
apoptotic genes are upregulated at 24 h p.i., and this pattern is
associated with the death of 75% of the mice by day 4. In
contrast, infection with icHC/SZ/61/03 causes upregulation of
more apoptotic genes at 24 h p.i. and is associated with a 100%
mortality rate by the end of day 3. Additional cell cycle regu-
lation observed in icHC/SZ/61/03-infected mice appears to be
a result of increased lung damage. Klf6 expression was
uniquely upregulated during lethal infection and has been
linked to transforming growth factor beta-related repair of
tissue damage (5). Although this repair mechanism is activated
by 24 h p.i., it is unable to counteract the inflammatory damage
already under way. As a result, we describe the icHC/SZ/61/03
host response as showing “enhanced lethality” due to the ad-
ditional components of regulation identified in the lethality-
associated network.
Although several other animal models of SARS-CoV infec-
tion have been described (12, 33, 36, 44, 45, 52), these models
rarely showed lethality. The results varied, ranging from
asymptomatic virus replication to pulmonary pathology with
visible clinical symptoms. The mouse models of virus-induced
ARDS used in this study lead to clinical symptoms in mice and
more accurately recapitulate the age-related pathogenic phe-
notype seen in human populations, suggesting this system is a
relevant model to study the acute phase of SARS-CoV patho-
genesis and virus-induced ARDS. The time course of our study
was focused on the exudative phase of ARDS, characterized by
DAD and hyaline membrane formation (47), with a lethal
outcome 3 to 4 days p.i.; therefore, mechanisms of fibrosis and
tissue repair could not be determined. However, since several
cytokines involved in fibrosis are induced in our model, we
predict that the survival of lethally infected aged mice could be
extended to the fibrotic phase of ARDS by using sublethal
infection. How this time course extension would affect host
response kinetics is of great interest. Future studies, using
knockout mice and depletion studies, will investigate the roles
of ARDS-associated cytokines, transforming growth factor
beta-related repair mechanisms, complement cascades, cell cy-
cle regulation, and caspase-directed apoptosis during acute
virus infection with the goal of promoting normal tissue repair
and inhibiting lethal disease in order to determine direct con-
tributions to respiratory death. These studies, including com-
parative work with young and aged mice with low- and highly
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pathogenic influenza, may provide considerable insight into
the effects of aging on early and/or aberrant host response.
In conclusion, the genomics data presented in this study
have established two new models of virus-induced ARDS.
These data provide several target cytokines that are associated
with the development of ARDS and have identified several
genes and pathways that potentially play roles in SARS-CoV
pathogenesis. These genes and pathways will be valuable as
candidates for future studies of the mechanism of SARS-CoV
lethality and as potential targets for treatment. In addition,
these new models of virus-induced ARDS will be invaluable
for comparative analysis with other virus-induced ARDS mod-
els and may provide insight into common mechanisms of
ARDS pathophysiology leading to death.
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